Medication safety in cancer patients

Anticancer drug treatment is often associated with serious adverse events, some of which can be avoided or mitigated by appropriate supportive therapy. To improve medication safety in cancer patients, our research group is developing interprofessional care models based on structured medication management. Within this context, the interprofessional care consists of medication reviews that include drug interaction checks, individualised supportive therapy, and patient counseling on how to deal with adverse drug reactions that are likely to occur.

Our projects in this regard include the development, validation, and use of patient-reported outcomes (PRO) measurement tools, e.g., the PRO version of the Common Terminology Criteria for Adverse Events (CTCAE). For oral anticancer therapy, a questionnaire is currently being developed to measure patients' medication literacy.